14h
Distinct metabolic signature found in patients with heart failure with preserved ejection fraction
What exactly happens in the hearts of patients with heart failure with preserved ejection fraction (HFpEF)—and how can this ...
U.S. Launch of MYQORZO® (aficamten) in Late January Met with Strong Demand; Over 275 HCPs Prescribed MYQORZO to an estimated 680 Patients in ...
A new Scientific Statement from the Heart Failure Society of America (HFSA) challenges longstanding ambiguity in the ...
KCCQ (Kansas City Cardiomyopathy Questionnaire): A standardized, patient-reported outcome tool that quantifies symptoms, functional status, and quality of life in heart failure patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results